Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain

ClinicalTrials.gov ID: NCT03429049

Public ClinicalTrials.gov record NCT03429049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3, randomized, double-blind, placebo-controlled, single injection, 52-week study to evaluate the analgesic efficacy and safety of a single intra-articular (IA) CNTX-4975-05 (capsaicin), compared to IA placebo, in subjects with chronic, moderate-to-severe osteoarthritis (OA) knee pain.

Study identification

NCT ID
NCT03429049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Centrexion Therapeutics
Industry
Enrollment
332 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 24, 2018 (Actual)
Primary completion
Nov 22, 2019 (Actual)
Completion
Nov 22, 2019 (Actual)
Last update posted
Jul 26, 2022

2018 – 2019

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
31
Facility City State ZIP Site status
Alabama Orthopaedic Center - Research Birmingham Alabama 35209 —
Cahaba Research, Inc Birmingham Alabama 35242 —
Coastal Clinical Research, Inc Mobile Alabama 36608 —
Noble Clinical Research, LLC Tucson Arizona 85704 —
Orange County Research Institute Anaheim California 92801 —
Core Healthcare Group Cerritos California 90703 —
Biosolutions Clinical Research Center La Mesa California 91942 —
Providence Clinical Research North Hollywood California 91606 —
Medical Associates Research Group San Diego California 92123 —
Encompass Clinical Research Spring Valley California 91978 —
Tampa Bay Medical Research, Inc Clearwater Florida 33761 —
Avail Clinical Research, LLC DeLand Florida 32720 —
M&M Medical Center, Inc Miami Florida 33185 —
Sensible Healthcare, LLC Ocoee Florida 34761 —
Jewett Orthopaedic Orlando Florida 32822 —
Clinical Research of West Florida, Inc. Tampa Florida 33603 —
Drug Studies America Marietta Georgia 30060 —
Georgia Institute for Clinical Research, LLC Marietta Georgia 30060 —
Atlanta Orthopaedic Institute, LLC Stockbridge Georgia 30281 —
MediSphere Medical Research Center, LLC Evansville Indiana 47714 —
Mid America PolyClinic Overland Park Kansas 66210 —
Tufts Medical Center Boston Massachusetts 02111 —
Tristan Medical Enterprises PC, dba North Attleboro Massachusetts 02760 —
Medical Research Associates, Inc Traverse City Michigan 49686 —
Sundance Clinical Research, LLC St Louis Missouri 63141 —
Clinical Research Consortium Las Vegas Nevada 89119 —
Hassman Research Institute Berlin New Jersey 08009 —
Bone Joint & Spine Surgeons, Inc Toledo Ohio 43623 —
Tekton Research, Inc Austin Texas 78745 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Clinical Investigations of Texas Plano Texas 75075 —
Ortho Virginia Arlington Virginia 22205 —
Charlottesville Medical Research Center, LLC Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03429049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03429049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →